Julie Lang

机构：University of Colorado Cancer Center, University of Colorado Anschutz, University of Colorado Denver · ORCID：0000-0003-2424-8222

发表论文 193 篇 · 总被引 2296 次 · h-index 25

代表论文

• Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer (2025 · Cancer Research Communications · 被引 4)
• Claudin-4 as a dual regulator of genome stability and immune evasion in high grade serous ovarian cancer (2025 · Scientific Reports · 被引 1)
• Supplementary Figure S7 from Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer (2025)
• Supplementary Table 1 from Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer (2025)
• Table 1 from Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer (2025)
• Supplementary Figure S9 from Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer (2025)